There is recent evidence that the immune response may play a role in the central nervous system during embryogenesis, neonatal development, normal healthy adult life, trauma, and disease. Leukocytes regularly traffic to and from the brain and secrete cytokines which can alter the morphology and function of resident glial cells. Primary myelination and remyelination after trauma/disease are probably mediated by the oligodendrocyte or its precursor, both capable of proliferation and differentiation. We have recently identified, purified, and characterized a T lymphokine from Mo cells, glial growth promoting factor (GGPF), which is one of the first glial specific lymphokines to be described and the first such factor shown to be specific for oligodendrocytes. With this technique we can purify large amounts of natural GGPF necessary for the generation of antibody and primary amino acid sequencing. In addition, we are screening a Mo expression cDNA library for recombinant proteins that stimulate oligodendrocytes to proliferate. This is the same technique that was used to clone human granulocyte-macrophage colony stimulating factor (GM-CSF). We wish to obtain cDNA clones encoding GGPF and use purified natural or recombinant GGPF for further biochemical and biological characterization. The Mo expression library consists of cDNA inserts in the 91023(B) expression vector which are transiently transfected into COS monkey kidney cells. Once we have isolated cDNA clones encoding GGPF, confirmation of the biochemical identity of natural and recombinant GGPF will be by a nucleotide and amino acid sequence comparison, molecular weight comparison, and binding of recombinant GGPF by anti-natural GGPF antibodies. Biological characterization will assess proliferation of primary neonatal and adult rat and human oligodendrocytes, induction of differentiation, and remyelination in cerebellar explant cultures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023741-02
Application #
3407562
Study Section
Neurology C Study Section (NEUC)
Project Start
1986-07-01
Project End
1989-06-30
Budget Start
1987-07-01
Budget End
1989-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Hospitals
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Otero, G C; Merrill, J E (1997) Response of human oligodendrocytes to interleukin-2. Brain Behav Immun 11:24-38
Otero, G C; Merrill, J E (1995) Molecular cloning of IL-2R alpha, IL-2R beta, and IL-2R gamma cDNAs from a human oligodendroglioma cell line: presence of IL-2R mRNAs in the human central nervous system. Glia 14:295-302
Hofman, F M; Hinton, D R; Baemayr, J et al. (1991) Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 58:331-42
Merrill, J E; Kagan, J M; Schmid, I et al. (1989) T cell lines established from multiple sclerosis cerebrospinal fluid T cells using human retroviruses. J Neuroimmunol 21:213-26
Merrill, J E; Matsushima, K (1988) Production of and response to interleukin 1 by cloned human oligodendroglioma cell lines. J Biol Regul Homeost Agents 2:77-86